Q4 2020 Holdings
Filed 2021-02-16 | 85 holdings | $15.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arvinas Inc(ARVN) | COM | 04335A105 | $4.7M | 55,000 | 31.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $2.9M | 17,556 | 19.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $2.6M | 235,066 | 17.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $1.4M | 80,282 | 9.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $820.0K | 110,000 | 5.4% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $776.0K | 120,000 | 5.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $735.0K | 3,000 | 4.9% |
| Actinium Pharmaceuticals Inc(ATNM) | COM | 00507W206 | $702.0K | 90,000 | 4.7% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $239.0K | 8,505 | 1.6% |
| Vericel Corp(VCEL) | COM | 92346J108 | $8.7K | 281,346 | 0.1% |
| Biogen IncCall | CALL | 09062X903 | $7.3K | 30,000 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $6.4K | 200,000 | 0.0% |
| Delcath SYS Inc(DCTH) | COM NEW | 24661P807 | $6.3K | 351,616 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $5.8K | 175,000 | 0.0% |
| Amryt Pharma PLC | SPONSORED ADS | 03217L106 | $5.7K | 402,556 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $5.0K | 227,388 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $4.7K | 217,203 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $4.6K | 100,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $4.4K | 20,000 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $4.3K | 530,000 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $4.3K | 100,000 | 0.0% |
| Tcr2 Therapeutics Inc | COM | 87808K106 | $4.2K | 136,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $4.0K | 185,000 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $3.9K | 600,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $3.9K | 322,917 | 0.0% |
| Cellectar Biosciences Inc | COM PAR | 15117F500 | $3.7K | 1,772,848 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $3.3K | 53,766 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $2.9K | 90,000 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $2.8K | 406,665 | 0.0% |
| Evogene LTD(EVGN) | SHS | M4119S104 | $2.8K | 600,000 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $2.4K | 215,071 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $2.4K | 18,825 | 0.0% |
| Verastem Inc | COM | 92337C104 | $2.4K | 1,135,753 | 0.0% |
| Affimed N V | COM | N01045108 | $2.3K | 400,000 | 0.0% |
| Renalytix AI PLC | ADS | 75973T101 | $2.3K | 141,253 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $2.2K | 38,620 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $2.2K | 30,000 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $2.2K | 135,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $2.0K | 16,131 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $1.9K | 440,955 | 0.0% |
| Compugen LTD(CGEN) | ORD | M25722105 | $1.8K | 150,550 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $1.7K | 51,433 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $1.7K | 263,951 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $1.6K | 110,000 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $1.5K | 20,000 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $1.5K | 30,834 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $1.4K | 130,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $1.4K | 16,500 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $1.3K | 7,509 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $1.2K | 25,000 | 0.0% |